A lot of attention was garnered by an article which I published on June 1 titled 'A Theory Behind Fda Approval Delays'. The article, linked and reprinted on discussion boards as far away as Germany, gave investors a new point of view from which to contemplate the matter of Fda drug approval delays and it redirected discussions along new paths never before considered.

After reading the article, which was reprinted at WallStreet-Online in Germany, one investor proudly contributed on beha... Read More

0 comments View Entry

The Fda has fallen weeks behind schedule in responding to select NDA's and PDUFA's. While people across the globe continue to fall ill, suffer and die from disease and debilitations, American drug research and development companies such as Cell Therapeutics (NASDAQ:CTIC), Hemispherx Biopharma (AMEX:HEB), BioDelivery Sciences International (NASDAQ:BDSI), Discovery Laboratories (NASDAQ:DSCO), Acura Phamaceuticals (NASDAQ:ACUR), King Pharmaceuticals (NYSE:KG) and Genta (OTC:GNTA) sit by anxiousl... Read More

0 comments View Entry